Related Experiment Video
Updated: Aug 4, 2026
09:54
Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
Published on: August 10, 2012
[Function and therapeutic potential of the dopamine D3 receptor]
1Unité de Neurobiologie et Phamacologie moléculaire (U 109) de l'INSERM, Centre Paul-Broca, Paris.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales
|April 2, 1999
Summary
The D3 receptor, targeted by antipsychotics, plays a role in emotions and reward. Its expression is influenced by dopamine, impacting Parkinson's disease and potentially schizophrenia.
Area of Science:
- Neuropharmacology: Investigating dopamine receptor subtypes and their signaling pathways.
- Molecular Psychiatry: Examining the role of dopamine D3 receptors in neurological and psychiatric disorders.
Context:
- Dopamine D3 receptors are selectively expressed in brain regions associated with emotion, motivation, and reward.
- Antipsychotic medications exhibit high affinity for the D3 receptor.
- D3 receptor function is intricately linked with the cyclic AMP (cAMP) pathway and interactions with D1 receptors.
Purpose:
- To elucidate the functional interactions between the dopamine D3 receptor and the cAMP pathway.
- To investigate the regulation of D3 receptor expression by dopamine innervation during development and in response to lesions.
- To explore the potential role of the D3 receptor in the therapeutic effects and side effects of levodopa treatment in Parkinson's disease.
Summary:
- D3 receptor stimulation affects cAMP levels and mitogenesis, indicating complex interactions with the cAMP pathway.
- D3 and D1 receptors colocalize and interact antagonistically or synergistically on gene expression in specific brain regions.
- Dopamine neuron lesions decrease D3 receptor expression, which can be rescued and ectopically induced by levodopa, leading to behavioral sensitization.
- Levodopa treatment in lesioned rats induces D3 receptor expression in the dorsal striatum, correlating with behavioral sensitization.
Impact:
- Findings suggest a role for D3 receptors in the evolving efficacy and adverse effects of levodopa in Parkinson's disease.
- The D3 receptor is implicated in drug addiction and schizophrenia, highlighting its potential as a therapeutic target.
- Selective D3 receptor agents may offer novel treatment strategies for schizophrenia and substance use disorders.
More Related Videos
Related Concept Videos
01:25Drug-Receptor Interaction: Agonist
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
01:25Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:22Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...